{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:23:23Z","timestamp":1788791003256,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005400","name":"American Society of Echocardiography","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.hfc.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T01:05:39Z","timestamp":1562979939000},"page":"435-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diagnosis and Prevention of Hypertensive Heart Failure"],"prefix":"10.1016","volume":"15","author":[{"given":"Andreas P.","family":"Kalogeropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Goulbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.hfc.2019.05.001_bib1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archinternmed.2009.40","article-title":"Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study","volume":"169","author":"Kalogeropoulos","year":"2009","journal-title":"Arch Intern Med"},{"issue":"16","key":"10.1016\/j.hfc.2019.05.001_bib2","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.hfc.2019.05.001_bib3","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.hfc.2019.05.001_bib4","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9932","key":"10.1016\/j.hfc.2019.05.001_bib5","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.hfc.2019.05.001_bib6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2019.05.001_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.117.032582","article-title":"Potential US population impact of the 2017 ACC\/AHA high blood pressure guideline","volume":"137","author":"Muntner","year":"2018","journal-title":"Circulation"},{"issue":"10064","key":"10.1016\/j.hfc.2019.05.001_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","article-title":"Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants","volume":"389","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.hfc.2019.05.001_bib9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.amjmed.2009.04.022","article-title":"Risk factors for heart failure: a population-based case-control study","volume":"122","author":"Dunlay","year":"2009","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.hfc.2019.05.001_bib10","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart failure long-term registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2019.05.001_bib11","doi-asserted-by":"crossref","first-page":"255124","DOI":"10.1016\/j.ijcard.2017.07.101","article-title":"Heart failure with mid-range ejection fraction in patients admitted to internal medicine departments: findings from the RICA Registry","volume":"255","author":"Guisado-Espartero","year":"2018","journal-title":"Int J Cardiol"},{"issue":"16","key":"10.1016\/j.hfc.2019.05.001_bib12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/hrt.2011.225482","article-title":"Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study","volume":"97","author":"Butler","year":"2011","journal-title":"Heart"},{"issue":"33","key":"10.1016\/j.hfc.2019.05.001_bib13","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2019.05.001_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"7","key":"10.1016\/j.hfc.2019.05.001_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.echo.2015.05.002","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)","volume":"28","author":"Marwick","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"6","key":"10.1016\/j.hfc.2019.05.001_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/jhh.2011.104","article-title":"Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies","volume":"26","author":"Cuspidi","year":"2012","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.hfc.2019.05.001_bib17","doi-asserted-by":"crossref","first-page":"270302","DOI":"10.1016\/j.ijcard.2018.06.031","article-title":"Pre-hypertension and subclinical cardiac damage: a meta-analysis of echocardiographic studies","volume":"270","author":"Cuspidi","year":"2018","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2019.05.001_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/HYPERTENSIONAHA.118.12114","article-title":"High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population","volume":"73","author":"Cuspidi","year":"2019","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.hfc.2019.05.001_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tcm.2018.09.004","article-title":"Silent myocardial infarction and risk of heart failure: current evidence and gaps in knowledge","volume":"29","author":"Soliman","year":"2019","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.hfc.2019.05.001_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11739-016-1527-2","article-title":"Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension","volume":"12","author":"Rendina","year":"2017","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10.1016\/j.hfc.2019.05.001_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.acvd.2010.11.013","article-title":"Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature","volume":"104","author":"Valensi","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.hfc.2019.05.001_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjcard.2013.09.028","article-title":"Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction","volume":"113","author":"Velagaleti","year":"2014","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2019.05.001_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.HYP.0000154822.37141.f6","article-title":"Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value","volume":"45","author":"Verdecchia","year":"2005","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.hfc.2019.05.001_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jacc.2018.10.038","volume":"73","author":"Writing Group","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2019.05.001_bib25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"Yancy","year":"2017","journal-title":"J\u00a0Card Fail"},{"issue":"1","key":"10.1016\/j.hfc.2019.05.001_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.hfc.2019.05.001_bib27","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/0735-1097(95)00269-5","article-title":"Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach","volume":"26","author":"Norman","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2019.05.001_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ehf2.12151","article-title":"Association between electrocardiographic and echocardiographic markers of stage B heart failure and cardiovascular outcome","volume":"4","author":"Yang","year":"2017","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.hfc.2019.05.001_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"10","key":"10.1016\/j.hfc.2019.05.001_bib30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.amjcard.2018.01.040","article-title":"Comorbidities, sociodemographic factors, and hospitalizations in outpatients with heart failure and preserved ejection fraction","volume":"121","author":"Georgiopoulou","year":"2018","journal-title":"Am J Cardiol"},{"issue":"27","key":"10.1016\/j.hfc.2019.05.001_bib31","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2019.05.001_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jacc.2014.10.044","article-title":"Exercise limitation associated with asymptomatic left ventricular impairment: analogy with stage B heart failure","volume":"65","author":"Kosmala","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2019.05.001_bib33","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","article-title":"Prevention and control of hypertension: JACC health promotion series","volume":"72","author":"Carey","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2019.05.001_bib34","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1097\/HJH.0000000000000692","article-title":"The prognostic legacy of left ventricular hypertrophy: cumulative evidence after the MAVI study","volume":"33","author":"Angeli","year":"2015","journal-title":"J\u00a0Hypertens"},{"issue":"5","key":"10.1016\/j.hfc.2019.05.001_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.117.028441","article-title":"Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)","volume":"136","author":"Soliman","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2019.05.001_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2010.427","article-title":"Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk","volume":"171","author":"Sciarretta","year":"2011","journal-title":"Arch Intern Med"},{"issue":"19","key":"10.1016\/j.hfc.2019.05.001_bib37","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","article-title":"Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies","volume":"275","author":"Schmieder","year":"1996","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hfc.2019.05.001_bib38","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/HYPERTENSIONAHA.109.136655","article-title":"Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies","volume":"54","author":"Fagard","year":"2009","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.hfc.2019.05.001_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/08037050510008832","article-title":"Angiotensin-receptor blockers and diuretics--advantages of combination","volume":"14","author":"Mimran","year":"2005","journal-title":"Blood Press"},{"issue":"Suppl","key":"10.1016\/j.hfc.2019.05.001_bib40","doi-asserted-by":"crossref","first-page":"N59","DOI":"10.1093\/eurheartj\/16.suppl_N.59","article-title":"Angiotensin converting enzyme inhibition in asymptomatic left ventricular systolic dysfunction and early heart failure","volume":"16","author":"Konstam","year":"1995","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2019.05.001_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.106.666016","article-title":"Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial","volume":"116","author":"Colucci","year":"2007","journal-title":"Circulation"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619300376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619300376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:40:44Z","timestamp":1761554444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713619300376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1551713619300376"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2019.05.001","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Prevention of Hypertensive Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}